Skip to Content

Newron Pharmaceuticals SpA NWPHF Stock Quote

| Rating as of

Morningstar‘s Stock Analysis NWPHF

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics NWPHF

Company Profile NWPHF

Business Description

Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.

Via Antonio Meucci 3, Bresso
Milan, 20091, Italy
T +39 26103461
Industry Biotechnology
Most Recent Earnings
Fiscal Year End Dec 31, 2022
Stock Type
Employees 24